title: ARB may be superior to ACEI on treatment of Marfan's syndrome by blocking TGF-β mediated activation of ERK.
authors.forename: Yang
authors.initials: Y
authors.lastname: Yang
authors.forename: Yi
authors.initials: Y
authors.lastname: Cui
authors.forename: Dao-Quan
authors.initials: DQ
authors.lastname: Peng
mesh_terms: D057911:Angiotensin Receptor Antagonists / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000818:Animals; D004789:Enzyme Activation / Q000502:physiology*; D048049:Extracellular Signal-Regulated MAP Kinases / Q000378:metabolism*; D006801:Humans; D008382:Marfan Syndrome / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism; D051379:Mice; D016212:Transforming Growth Factor beta / Q000037:antagonists & inhibitors* / Q000378:metabolism; D016896:Treatment Outcome
chemical_list: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D016212:Transforming Growth Factor beta; D048049:Extracellular Signal-Regulated MAP Kinases